Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SAGE - Why Sage Therapeutics Stock Is Crashing Today


SAGE - Why Sage Therapeutics Stock Is Crashing Today

Sage Therapeutics (NASDAQ: SAGE) is having a tough time today. After releasing the long-awaited phase 3 trial results for its rapid-onset drug zuranolone as a treatment for major depressive disorder (MDD) this morning, the drugmaker's shares immediately hit the skids.

Sage's stock is down by a hefty 16.8% as of 11:25 a.m. ET Wednesday morning. Biotech heavyweight Biogen owns over 10% of Sage's outstanding shares, and the two biopharmaceutical companies have a joint development/commercialization agreement in place for zuranolone.

Image source: Getty Images.

Continue reading

For further details see:

Why Sage Therapeutics Stock Is Crashing Today
Stock Information

Company Name: Sage Therapeutics Inc.
Stock Symbol: SAGE
Market: NASDAQ
Website: sagerx.com

Menu

SAGE SAGE Quote SAGE Short SAGE News SAGE Articles SAGE Message Board
Get SAGE Alerts

News, Short Squeeze, Breakout and More Instantly...